Lisata Therapeutics Balance Sheet Health
Financial Health criteria checks 6/6
Lisata Therapeutics has a total shareholder equity of $33.4M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $38.2M and $4.8M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$35.86m |
| Equity | US$33.44m |
| Total liabilities | US$4.76m |
| Total assets | US$38.20m |
Recent financial health updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 8NE's short term assets ($37.7M) exceed its short term liabilities ($4.7M).
Long Term Liabilities: 8NE's short term assets ($37.7M) exceed its long term liabilities ($72.0K).
Debt to Equity History and Analysis
Debt Level: 8NE is debt free.
Reducing Debt: 8NE had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 8NE has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: 8NE has sufficient cash runway for 1.9 years if free cash flow continues to reduce at historical rates of 4.2% each year.